Department of Radiology, La Timone Hospital, Marseille, France.
Department of Oncology, La Timone Hospital, Marseille, France.
Ann Med. 2023 Dec;55(1):521-525. doi: 10.1080/07853890.2023.2174589.
Desmoid tumors (DT) are rare benign tumors with a local invasion potential and recurrence. It is characterized on histology by an abnormal fibroblastic proliferation in a collagenous stroma, in variable proportions leading to heterogeneity of the lesion signal on magnetic resonance imaging (MRI). Current guidelines propose watchful waiting but in case of progression or symptoms, cryotherapy may be a therapeutic option in its extra-abdominal form. Tumor recurrence is mostly detected based on post-contrast magnetic resonance imaging (MRI). Although DWI sequence is the key-sequence for tumor detection in oncologic imaging, there are very few data in literature on diffusion weighted imaging (DWI) in DT generally and even fewer on DT after cryotherapy. DWI changes after cryotherapy may be confusing and suspicious of residual tumor or tumor recurrence when displaying low ADC values; thus knowledge of possible DWI patterns after cryotherapy of DT seem paramount. We found that the early changes of DT after cryotherapy are hyperintensity on DWI sequence with low ADC values (<1.00 × 10mm/s), without corresponding enhancement and a later decrease in signal of the treated lesion on DWI. The freezing-thawing cycles of cryotherapy turn DT into gelatinous necrosis with a slow resorption rate, as reported in the only few studies referring of changes of DWI signals after cryotherapy, which are on renal and prostate models. Hyperintensity on DWI with low ADC values may be seen in early MRI follow-up after cryotherapy of extra-abdominal DT, corresponding with tumor necrosis changes and should not be mistaken with recurrence.KEY MESSAGESMagnetic resonance imaging is the modality of choice for desmoid tumor (DT) follow-up, mainly based on contrast uptake which make data on diffusion weighted imaging (DWI) very rare.Cryotherapy is an accepted therapeutic option for DT that will lead to tumor necrosis.Hyperintensity on DWI with low apparent diffusion coefficient values is a possible expected early pattern on DWI after cryotherapy of DT.
硬纤维瘤(DT)是一种罕见的良性肿瘤,具有局部侵袭性和复发性。其组织学特征为胶原基质中异常成纤维细胞增殖,导致病变信号在磁共振成像(MRI)上存在异质性。目前的指南建议密切观察,但如果病情进展或出现症状,冷冻疗法可能是一种治疗选择,尤其是对于腹腔外的病变。肿瘤复发主要通过增强 MRI 检测。虽然 DWI 序列是肿瘤成像中检测肿瘤的关键序列,但在硬纤维瘤中,DWI 的相关数据很少,在冷冻治疗后更是如此。冷冻治疗后 DWI 的变化可能会因 ADC 值较低而显示出低信号,从而导致对残留肿瘤或肿瘤复发的怀疑,因此了解冷冻治疗后 DWI 的可能模式似乎至关重要。我们发现,冷冻治疗后硬纤维瘤的早期变化是 DWI 序列上的高信号,ADC 值较低(<1.00×10mm/s),没有相应的增强,随后治疗部位的信号在 DWI 上降低。冷冻治疗的冻融循环使硬纤维瘤转变为胶样坏死,其吸收速度较慢,这在仅有的几项关于冷冻治疗后 DWI 信号变化的研究中有所报道,这些研究涉及肾脏和前列腺模型。在腹腔外硬纤维瘤冷冻治疗后的早期 MRI 随访中,可能会出现 DWI 高信号伴低 ADC 值,这与肿瘤坏死变化相对应,不应与复发混淆。
主要信息
磁共振成像(MRI)是硬纤维瘤(DT)随访的首选方式,主要基于对比剂摄取,因此关于弥散加权成像(DWI)的数据非常少见。
冷冻疗法是硬纤维瘤的一种可接受的治疗选择,可导致肿瘤坏死。
DWI 上的高信号伴低表观弥散系数值是硬纤维瘤冷冻治疗后 DWI 上的一种可能的早期模式。